NEW YORK (GenomeWeb) – The non-profit Transforming Medicine: The Elizabeth Kauffman Institute (TMed), which seeks to match patients with life-threatening diseases with the most appropriate treatments, officially launched today. 

Founded by Institute for Systems Biology President Lee Hood and others, Cambridge, Massachusetts-based TMed plans to develop a knowledgebase for evaluating patient information, including genetic and molecular data, to determine the best marketed and research-stage treatment for each individual. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.